Stay updated on Cabozantinib in RAI-Refractory DTC Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in RAI-Refractory DTC Clinical Trial page.
Latest updates to the Cabozantinib in RAI-Refractory DTC Clinical Trial page
- CheckyesterdayChange DetectedThe website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.SummaryDifference0.1%
- Check9 days agoChange DetectedThe website has been updated to Revision v2.11.0, while the previous version v2.10.5 has been removed, along with a notice regarding delays in displaying study record information.SummaryDifference0.9%
- Check16 days agoChange DetectedClinicalTrials.gov is addressing delays in displaying study record information, and the website has been updated to version 2.10.5, replacing the previous version 2.10.3.SummaryDifference0.8%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3.SummaryDifference0.1%
- Check52 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements in the latest release.SummaryDifference0.1%
- Check73 days agoChange DetectedThe study has been updated to version v2.10.0, replacing the previous version v2.9.7.SummaryDifference0.3%
Stay in the know with updates to Cabozantinib in RAI-Refractory DTC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in RAI-Refractory DTC Clinical Trial page.